Cargando…
A brief review of clinical trials involving manipulation of invariant NKT cells as a promising approach in future cancer therapies
In the recent years researchers have put a lot of emphasis on the possible immunotherapeutic strategies able to target tumors. Many studies have proven that the key role in recognition and eradication of cancer cells, both for mice and humans, is being conducted by the invariant natural killer T-cel...
Autores principales: | Waldowska, Małgorzata, Bojarska-Junak, Agnieszka, Roliński, Jacek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Polish Society of Experimental and Clinical Immunology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573892/ https://www.ncbi.nlm.nih.gov/pubmed/28860937 http://dx.doi.org/10.5114/ceji.2017.69361 |
Ejemplares similares
-
Intracellular IL-4 and IFN-γ expression in iNKT cells from patients with chronic lymphocytic leukemia
por: Bojarska-Junak, Agnieszka, et al.
Publicado: (2018) -
NKT and NKT-like Cells in Autoimmune Neuroinflammatory Diseases—Multiple Sclerosis, Myasthenia Gravis and Guillain-Barre Syndrome
por: Zarobkiewicz, Michał K., et al.
Publicado: (2021) -
Percentages of NKT cells in the tissues of patients with non-small cell lung cancer who underwent surgical treatment
por: Pyszniak, Maria, et al.
Publicado: (2014) -
Upper Respiratory Tract Colonization by Gram-Negative Rods in Patients with Chronic Lymphocytic Leukemia: Analysis of Risk Factors
por: Korona-Glowniak, Izabela, et al.
Publicado: (2012) -
Mouse Invariant Monoclonal Antibody NKT14: A Novel Tool to Manipulate iNKT Cell Function In Vivo
por: Scheuplein, Felix, et al.
Publicado: (2015)